We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · November 28, 2020

Chemotherapy or Allo-HSCT in High-Risk Ph-neg Adult ALL



Additional Info

Disclosure statements are available on the authors' profiles:

Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome-Negative Adult Lymphoblastic Leukemia
Blood 2020 Nov 04;[EPub Ahead of Print], JM Ribera, M Morgades, J Ciudad, P Montesinos, J Esteve, E Genesca, P Barba, J Ribera, I García Cadenas, MJ Moreno, D Martínez-Carballeira, A Torrent, P Martínez-Sánchez, S Monsalvo, C Gil, M Tormo, MT Artola, M Cervera, J González-Campos, C Rodríguez-Medina, A Bermúdez, A Novo, B Soria, R Coll, ML Amigo, A López, R Fernández Martín, J Serrano, S Mercadal, A Cladera, AD Giménez-Conca, MJ Peñarrubia, E Abella, F Vall-Llovera, JM Hernández-Rivas, A Garcia, JM Bergua Burgues, B de Rueda, MJ Sánchez-Sánchez, A Serrano, M Calbacho, N Alonso Vence, JÁ Méndez-Sánchez, R García-Boyero, M Olivares, S Barrena, L Zamora, I Granada, L Lhermitte, E Feliu, A Orfao

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading